The new Psoriasis and Psoriatic Arthritis Hub is now live

The new Psoriasis and Psoriatic Arthritis Hub is now live

The International Psoriasis Council (IPC) and Scientific Education Support (SES) are excited to announce a strategic collaboration for healthcare professionals (HCPs) in the fields of psoriasis and psoriatic arthritis. The aim of this collaboration is to achieve improved awareness, knowledge, and understanding of psoriasis, psoriatic arthritis, and other related diseases.

Today, SES has launched the new Psoriasis and Psoriatic Arthritis Hub, with IPC as the founding professional partner. This hub is an open-access online resource, dedicated to providing balanced, credible, and up-to-date medical education in psoriasis and psoriatic arthritis. The aim of the hub is to enhance knowledge on psoriasis and psoriatic arthritis through the multichannel dissemination of global advances related to classification, diagnosis, treatment, and management.

The Psoriasis and Psoriatic Arthritis Hub will share new data, evidence-based articles, therapy approvals, expert opinions, and international congress coverage to treatment teams and researchers around the world.

Activity such as this would not be possible without our supporter; therefore, we would like to take this opportunity to welcome UCB and thank them for their support. All hub content is developed independently by SES in collaboration with an expert steering committee; funders are allowed no direct influence on the content of the hub.

Speaking at the launch, Mia Hill, IME Director at SES, said:

“We are delighted to announce that the Psoriasis and Psoriatic Arthritis Hub is now live. Our vision for the hub is that every treatment team and researcher will have instant access to expert opinions and the latest evidence-based information on psoriasis and psoriatic arthritis to aid in treatment decisions and improve the lives of patients globally.

“IPC and SES believe that the Psoriasis and Psoriatic Arthritis Hub will become the solution for time-stretched HCPs to easily access up-to-date medical information to expedite learning and empower their treatment decisions. All hub content is guided by a steering committee of world-renowned experts, informed by patients, and endorsed by expert societies, in order to support HCPs worldwide.”


For more information on the Psoriasis and Psoriatic Arthritis Hub, please visit and for more information on the International Psoriasis Council, please visit

For media enquiries or to explore collaboration opportunities, please contact or


About psoriasis

Psoriasis is a chronic immune-mediated skin disease, which commonly manifests as erythematous plaques on the scalp, trunk, buttocks, and extensor aspects of the limbs. Psoriasis can be painful and disfiguring, impacting quality of life. It is also often associated with other autoimmune disorders, cardiovascular disease, and diabetes, impacting healthcare utilization and disease burden.

About psoriatic arthritis

Psoriatic arthritis, also known as PsA, is an inflammatory joint disease that develops in a significant minority of patients with psoriasis. Psoriatic arthritis is often underdiagnosed and undertreated, with a variable clinical course. Many patients with psoriatic arthritis experience progressive joint disease, impairing physical function and quality of life.

About Scientific Education Support (SES)

SES is an independent medical education organization that delivers community physician education through therapy hubs, community awareness and education through ‘Know’ education initiatives, and academic researcher education through Entrepreneurs in Clinical Academia (ECA) programs.

Over the past decade, SES has conceived, developed, launched, and managed a series of renowned hubs that support the advancement of medical education in the field of hemato-oncology, including the ALL Hub, AML Hub, GvHD Hub, Lymphoma Hub, MDS Hub, MPN Hub, and Multiple Myeloma Hub.

About the International Psoriasis Council (IPC)

The IPC is a community of physician experts working to improve the health of people with psoriasis around the world. The IPC focuses on helping dermatologists build expertise in psoriasis management and trains physicians to better care for people with psoriasis.